Depakote May Cause Cognitive Defects, FDA Warns

Law360, New York (July 1, 2011, 6:41 PM EDT) -- The U.S. Food and Drug Administration warned Thursday that women who take anti-seizure drug Depakote while pregnant are at increased risk of giving birth to children with cognitive impairments.

At age three, children whose mothers were on Depakote or another valproate sodium-based drug throughout their pregnancy scored lower on IQ tests than a control group whose mothers took other anti-seizure medications, the FDA said.

The agency has previously cautioned that Depakote could cause other birth defects. In December 2009, it told doctors that use of the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.